Enteropathy-associated T-cell lymphoma screening: Difference between revisions
(Created page with "__NOTOC__ {{Enteropathy-associated T-cell lymphoma}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing....") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Enteropathy-associated T-cell lymphoma}} | {{Enteropathy-associated T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | |||
==Overview== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma. | |||
==Screening== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Revision as of 20:56, 26 January 2016
|
Enteropathy-associated T-cell lymphoma Microchapters |
|
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Enteropathy-associated T-cell lymphoma screening On the Web |
|
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma screening |
|
Enteropathy-associated T-cell lymphoma screening in the news |
|
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.